Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2026)

Pacific Biosciences Of California has reported Return on Invested Capital for 5 years, with the latest figure at 0.35% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital fell 32.0% year-over-year to 0.35%; the trailing twelve-month figure through Mar 2026 stood at 0.35% (down 32.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.35%, down from 0.27% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q3 2023, with the low at 0.35% in Q1 2026.
• Average Return on Invested Capital over 5 years is 0.08%, with a median of 0.01% recorded in 2024.
• Year-over-year, Return on Invested Capital changed 0 bps in 2023 and sank 32 bps in 2026.
• Tracing PACB's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then increased by 5 bps to 0.0% in 2023, then sank by 140 bps to 0.01% in 2024, then slumped by 2603 bps to 0.27% in 2025, then slipped by 30 bps to 0.35% in 2026.
• The last three Return on Invested Capital figures came in at 0.35% (Q1 2026), 0.27% (Q4 2025), and 0.14% (Q3 2025), per Business Quant data.

Peer Comparison